论文部分内容阅读
目的研究分析胺碘酮治疗急性心肌梗死后室性心律失常的临床治疗效果及安全性。方法 70例急性心肌梗死后室性心律失常患者,随机分为实验组和对照组,每组35例。两组患者均接受常规治疗,在此基础上,对照组使用利多卡因治疗,实验组使用胺碘酮治疗,对比两组患者的临床治疗有效性和不良反应的发生率。结果实验组患者的临床治疗总有效率(91.43%)高于对照组(71.43%);实验组患者不良反应发生率(11.43%)低于实验组(2.86%),差异均具有统计学意义(P<0.05)。结论急性心肌梗死后室性心律失常患者给予胺碘酮治疗,临床治疗有效率高,不良反应小,值得在临床上推广使用。
Objective To study the clinical effect and safety of amiodarone in the treatment of ventricular arrhythmia after acute myocardial infarction. Methods Seventy patients with ventricular arrhythmia after acute myocardial infarction were randomly divided into experimental group and control group with 35 cases in each group. Both groups received routine treatment. On this basis, the control group was treated with lidocaine. The experimental group was treated with amiodarone. The clinical efficacy and incidence of adverse reactions were compared between the two groups. Results The total effective rate (91.43%) in the experimental group was significantly higher than that in the control group (71.43%). The incidence of adverse reactions in the experimental group (11.43%) was lower than that in the experimental group (2.86%), and the difference was statistically significant P <0.05). Conclusions Amiodarone is given to patients with ventricular arrhythmia after acute myocardial infarction. The clinical treatment is effective and the adverse reactions are small. It is worth to be popularized in clinic.